Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations

被引：25

作者：

Diefenbach, Catherine S. ^{[1
]}

Connors, Joseph M. ^{[2
]}

Friedberg, Jonathan W. ^{[3
,4
]}

Leonard, John P. ^{[5
]}

Kahl, Brad S. ^{[6
]}

Little, Richard F. ^{[7
]}

Baizer, Lawrence ^{[8
]}

Evens, Andrew M. ^{[9
,10
]}

Hoppe, Richard T. ^{[11
]}

Kelly, Kara M. ^{[12
]}

Persky, Daniel O. ^{[13
]}

Younes, Anas ^{[14
]}

Kostakaglu, Lale ^{[15
]}

Bartlett, Nancy L. ^{[6
]}

机构：

[1] NYU, Perlmutter Canc Ctr, 240 East 38th St,19th Floor, New York, NY 10016 USA

[2] BC Canc Agcy, Ctr Lymphoid Canc, Vancouver, BC, Canada

[3] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA

[4] Univ Rochester, Med Ctr, Div Hematol Oncol, Rochester, NY 14642 USA

[5] Weil Cornell Univ, Dept Med, New York, NY USA

[6] Washington Univ, Dept Med, Div Oncol, St Louis, MO USA

[7] Tufts Univ, Sch Med, Div Canc Treatment & Diag, Boston, MA 02111 USA

[8] Tufts Univ, Sch Med, Coordinating Ctr Clin Trials, Boston, MA 02111 USA

[9] Tufts Univ, Sch Med, Tufts Canc Ctr, Boston, MA 02111 USA

[10] Tufts Univ, Sch Med, Div Hematol Oncol, Boston, MA 02111 USA

[11] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA

[12] Columbia Univ, Div Pediat Hematol Oncol Stem Cell Transplant, Med Ctr, New York, NY USA

[13] Univ Arizona, Ctr Canc, Dept Med, Tucson, AZ USA

[14] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA

[15] Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA

来源：

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2017年 / 109卷 / 04期

基金：

美国国家卫生研究院;

关键词：

REED-STERNBERG CELLS; EPSTEIN-BARR-VIRUS; INTERNATIONAL PROGNOSTIC SCORE; INVOLVED-FIELD RADIOTHERAPY; TUMOR-ASSOCIATED MACROPHAGES; COOPERATIVE-ONCOLOGY-GROUP; RADIATION-THERAPY; BRENTUXIMAB VEDOTIN; PHASE-II; DEFINED SUBGROUPS;

D O I：

10.1093/jnci/djw249

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The National Clinical Trials Network lymphoid malignancies Clinical Trials Planning Meeting (CTPM) occurred in November of 2014. The scope of the CTPM was to prioritize across the lymphoid tumors clinically significant questions and to foster strategies leading to biologically informed and potentially practice changing clinical trials. This review from the Hodgkin lymphoma (HL) subcommittee of the CTPM discusses the ongoing clinical challenges in HL, outlines the current standard of care for HL patients from early to advanced stage, and surveys the current science with respect to biomarkers and the landscape of ongoing clinical trials. Finally, we suggest areas of unmet need in HL and elucidate promising therapeutic strategies to guide future HL clinical trials planning across the NCTN.

引用

页数：12

共 50 条

[41] Clinical Trial Availability in Adolescent and Young Adult Patients with Non-Hodgkin Lymphoma
Crawley, Melissa Ann
Stein, Matthew K.
Patel, Kruti
Martin, Michael G.
BLOOD, 2016, 128 (22)
[42] Hodgkin lymphoma: Current and future therapeutic strategies
Turpin, Anthony
Michot, Jean-Marie
Kempf, Emmanuelle
Mazeron, Renaud
Dartigues, Peggy
Terroir, Marie
Boros, Angela
Bonnetier, Serge
Castilla-Llorente, Cristina
Coman, Tereza
Danu, Alina
Ghez, David
Pilorge, Sylvain
Arfi-Rouche, Julia
Dercle, Laurent
Soria, Jean-Charles
Carde, Patrice
Ribrag, Vincent
Ferme, Christophe
Lazarovici, Julien
BULLETIN DU CANCER, 2018, 105 (01) : 81 - 98
[43] Current treatment and immunotherapy of Hodgkin's lymphoma
Klimm, Beate
Schnell, Roland
Diehl, Volker
Energt, Andreas
HAEMATOLOGICA, 2005, 90 (12) : 1680 - 1692
[44] Current directions in the treatment of classical Hodgkin lymphoma
Keller, Frank G.
Kahl, Brad
Friedberg, Jonathan W.
EJHAEM, 2023, 4 (04): : 908 - 911
[45] Current controversies in the management of Hodgkin's lymphoma
Chang, Julie
Bradley, Kristin
Kahl, Brad
ONCOLOGY-NEW YORK, 2007, 21 (04): : 445 - 446
[46] CURRENT STRATEGIES IN REFRACTORY OR RELAPSED HODGKIN LYMPHOMA
von Tresckow, B.
Borchmann, P.
Fuchs, M.
Pluetschow, A.
Engert, A.
HAEMATOLOGICA, 2010, 95 : S31 - S31
[47] Current and future immunotherapeutic approaches in Hodgkin lymphoma
Broeckelmann, Paul J.
Borchmann, Peter
Engert, Andreas
LEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2014 - 2024
[48] Current treatment of older Hodgkin Lymphoma patients
Boell, B.
ONKOLOGIE, 2013, 36 : 90 - 91
[49] Current treatment strategies in Hodgkin's lymphoma
Ansén, S
Sieber, M
Wingbermühle, K
Josting, A
Diehl, V
INTERNIST, 2002, 43 (12): : 1544 - +
[50] Current approaches to the management of pediatric hodgkin lymphoma
Freed J.
Kelly K.M.
Pediatric Drugs, 2010, 12 (2) : 85 - 98

← 1 2 3 4 5 →